FGFR2 fusions have been observed in 10–20% of iCCA patients; they are mutually exclusive with KRAS/BRAF mutations and often co-occur with BAP1 alterations [43,90,141]. The gene discussed is KRAS; the disease is infantile convulsions and choreoathetosis.